Niuxian tea produced by Harbin Pharmaceutical Sanjing is not a medicine, but a health care product. It has no therapeutic effect and can only be used as an adjuvant treatment.
As early as February 7, 2007, the State Food and Drug Administration of the United States issued a summary notice of the fourth illegal drug advertisements in 2006. "Niuxian Tea" produced by Harbin Pharmaceutical Group Sanjing He Qian Pharmaceutical Co., Ltd. has the main functions of cooling blood and promoting blood circulation, nourishing yin and moistening dryness, expelling wind and relieving itching, and is suitable for white blood and hot air dryness, mutual resistance of blood stasis and toxin, with symptoms such as scaly hypertrophy, dry skin and itching. In the advertisement, the drug claims that "indications are psoriasis, tinea versicolor, allergy, neurodermatitis and eczema", "safety, no recurrence, so-called skin disease terminator, immediate effect" and "three months to get rid of chronic skin diseases". The advertisement arbitrarily expanded the scope of functional indications approved by the food and drug administration, including unscientific assertions and guarantees indicating efficacy, which violated the Advertising Law and the Standards for Examination of Drug Advertisements and seriously deceived and misled consumers.